Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Animal Pharm Podcast #12: Could an IPO be the most viable option for Elanco?

With a decision on Elanco's future due in a week, Animal Pharm editor Joseph Harvey provides a recap of the company's situation and what can be expected over the next seven days.

The podcast below covers Elanco's financial performance from 1990 until now, the firm's R&D situation and the four potential scenarios that Eli Lilly could opt for next week.

The podcast also features the results of Animal Pharm's poll on the future of Elanco, which has been running over the past week. The poll is still active and the results mentioned in the podcast were accurate at the time of recording. The latest poll voting is displayed below.

Elanco's future will become a lot clearer on July 24, when Eli Lilly publishes its second-quarter results. Lilly has been conducting a strategic review of its animal health division over the past nine months.


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts